Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Garden, Adam S."" wg kryterium: Autor


Tytuł :
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Autorzy :
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Lin TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Sikora AG; ENT Section, Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.; Bobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, One Baylor Plaza, MS: NA102, Houston, TX, 77030, USA.
Lai SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abusaif A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA. .; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA. .
Sandulache VC; ENT Section, Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. .; Bobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, One Baylor Plaza, MS: NA102, Houston, TX, 77030, USA. .; Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2020 Sep 23; Vol. 20 (1), pp. 912. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Squamous Cell/*etiology
Carcinoma, Squamous Cell/*mortality
Oropharyngeal Neoplasms/*etiology
Oropharyngeal Neoplasms/*mortality
Papillomavirus Infections/*mortality
Smoking/*mortality
Alphapapillomavirus/isolation & purification ; Carcinoma, Squamous Cell/epidemiology ; Carcinoma, Squamous Cell/pathology ; Female ; Humans ; Male ; Middle Aged ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/virology ; Papillomavirus Infections/pathology ; Retrospective Studies ; Smoking/pathology ; Survival Analysis
Czasopismo naukowe
Tytuł :
Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model.
Autorzy :
Ng SP; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Ajayi T; Department of Computational and Applied Mathematics, Rice University, Houston, Texas.
Schaefer AJ; Department of Computational and Applied Mathematics, Rice University, Houston, Texas.
Pollard C 3rd; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Bahig H; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Garden AS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed ASR; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Feb 15; Vol. 126 (4), pp. 749-756. Date of Electronic Publication: 2019 Nov 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Markov Chains*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Monitoring, Physiologic/*methods
Algorithms ; Carcinoma, Squamous Cell/diagnostic imaging ; Cohort Studies ; Female ; Head and Neck Neoplasms/diagnostic imaging ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Models, Biological ; Neoplasm Recurrence, Local ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.
Autorzy :
Mohamed ASR; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; Department of Clinical Oncology, University of Alexandria, Alexandria, Egypt.
Smith BD; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; University of Texas McGovern Medical School, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, U.S.A.
Smith JB; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; University of Texas McGovern Medical School, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, U.S.A.
Sevak P
Malek JS
Kanwar A
Browne T
Gunn GB; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Garden AS; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Frank SJ; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Morrison WH; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Phan J; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Zafereo M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Skinner H; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Hessel AE; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Thekdi AA; Department of Otolaryngology, Houston Methodist Hospital, Houston, Texas, U.S.A.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Fuller CD; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas, U.S.A.
Rosenthal DI; Multidisciplinary Larynx Cancer Working Group from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2020 Jan; Vol. 130 (1), pp. 146-153. Date of Electronic Publication: 2019 Feb 12.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Glottis*
Carcinoma, Squamous Cell/*radiotherapy
Laryngeal Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Carcinoma, Squamous Cell/pathology ; Carotid Arteries ; Case-Control Studies ; Female ; Humans ; Laryngeal Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Organ Sparing Treatments ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Not All 30-Gy Regimens Are Equal.
Autorzy :
Garden AS; Adam S. Garden, MD, University of Texas MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 20; Vol. 37 (36), pp. 3558-3559. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Squamous Cell*
Papillomaviridae*
Papillomavirus Infections*
Chemoradiotherapy, Adjuvant ; Humans ; Oropharynx ; Radiotherapy Dosage
Opinia redakcyjna
Tytuł :
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Autorzy :
Lin TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Baylor College of Medicine, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jethanandani A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Debnam JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2019 May 01; Vol. 125 (9), pp. 1536-1546. Date of Electronic Publication: 2019 Jan 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Squamous Cell/*diagnosis
Carcinoma, Squamous Cell/*pathology
Lymph Nodes/*diagnostic imaging
Oropharyngeal Neoplasms/*diagnosis
Oropharyngeal Neoplasms/*pathology
Papillomavirus Infections/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/therapy ; Carcinoma, Squamous Cell/virology ; Cervical Vertebrae/diagnostic imaging ; Chemoradiotherapy/statistics & numerical data ; Cohort Studies ; Female ; Head and Neck Neoplasms/diagnosis ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/therapy ; Head and Neck Neoplasms/virology ; Humans ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Oropharyngeal Neoplasms/therapy ; Oropharyngeal Neoplasms/virology ; Papillomavirus Infections/complications ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/therapy ; Pharynx/diagnostic imaging ; Prognosis ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/pathology ; Squamous Cell Carcinoma of Head and Neck/therapy ; Squamous Cell Carcinoma of Head and Neck/virology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry.
Autorzy :
Amit M; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson K; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zaveri J; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lewin J; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kupferman ME; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hessel AC; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Goepfert RP; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brandon Gunn G; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferraratto R; Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dave Fuller C; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tam S; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gross ND; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2019 Apr; Vol. 91, pp. 13-20. Date of Electronic Publication: 2019 Feb 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Reported Outcome Measures*
Carcinoma, Squamous Cell/*therapy
Oropharyngeal Neoplasms/*therapy
Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Prospective Studies ; Registries
Czasopismo naukowe
Tytuł :
Postoperative Radiation Therapy for Metastatic Cervical Adenopathy.
Autorzy :
Garden AS; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX. Electronic address: .
Reddy JP; Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Seminars in radiation oncology [Semin Radiat Oncol] 2019 Apr; Vol. 29 (2), pp. 144-149.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Radiotherapy, Adjuvant*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Lymphatic Metastasis/*radiotherapy
Carcinoma, Squamous Cell/surgery ; Head and Neck Neoplasms/surgery ; Humans ; Lymph Node Excision ; Neck Dissection ; Neoplasm Recurrence, Local ; Radiotherapy Dosage ; Risk Factors
Czasopismo naukowe
Tytuł :
Development and validation of a 3D-printed bolus cap for total scalp irradiation.
Autorzy :
Baltz GC; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Chi PM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Wong PF; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Craft DF; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Kry SF; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Lin SSH; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Smith SA; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Howell RM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Pokaż więcej
Źródło :
Journal of applied clinical medical physics [J Appl Clin Med Phys] 2019 Mar; Vol. 20 (3), pp. 89-96. Date of Electronic Publication: 2019 Mar 01.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Phantoms, Imaging*
Carcinoma, Squamous Cell/*radiotherapy
Printing, Three-Dimensional/*instrumentation
Scalp/*radiation effects
Skin Neoplasms/*radiotherapy
Aged ; Humans ; Male ; Radiometry ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Intensity-Modulated
Czasopismo naukowe
Tytuł :
Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
Autorzy :
Heah H; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Otolaryngology, Singapore General Hospital, Singapore.
Goepfert RP; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Otolaryngology, Singapore General Hospital, Singapore.
Kupferman ME; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Holsinger FC; Department of Otolaryngology - Head and Neck Surgery, Stanford University Medical Center, Stanford, California.
Hessel AC; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gross ND; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2018 Nov; Vol. 40 (11), pp. 2507-2513. Date of Electronic Publication: 2018 Aug 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Weight Loss*
Carcinoma, Squamous Cell/*surgery
Enteral Nutrition/*statistics & numerical data
Gastrostomy/*statistics & numerical data
Oropharyngeal Neoplasms/*surgery
Robotic Surgical Procedures/*methods
Adult ; Aged ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Chemoradiotherapy/methods ; Cohort Studies ; Enteral Nutrition/methods ; Female ; Follow-Up Studies ; Gastrostomy/methods ; Humans ; Incidence ; Male ; Middle Aged ; Multivariate Analysis ; Natural Orifice Endoscopic Surgery/methods ; Oropharyngeal Neoplasms/mortality ; Oropharyngeal Neoplasms/pathology ; Quality Improvement ; Regression Analysis ; Retrospective Studies ; Risk Assessment ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
Autorzy :
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Volpe S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Milan, Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2018 Apr 01; Vol. 124 (7), pp. 1415-1427. Date of Electronic Publication: 2018 Jan 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Squamous Cell/*mortality
Head and Neck Neoplasms/*mortality
Neoplasms, Unknown Primary/*mortality
Radiotherapy, Intensity-Modulated/*mortality
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/radiotherapy ; Carcinoma, Squamous Cell/secondary ; Female ; Follow-Up Studies ; Head and Neck Neoplasms/radiotherapy ; Head and Neck Neoplasms/secondary ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasms, Unknown Primary/pathology ; Neoplasms, Unknown Primary/radiotherapy ; Prognosis ; Radiotherapy Dosage ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy.
Autorzy :
Quinlan-Davidson SR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Radiation Oncology, Allentown Radiation Oncology Associates, Allentown, PA, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Johnson FM; Department of Thoracic/Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Skinner H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillenwater AM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
William WN; Department of Thoracic/Head and Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wong AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Oral oncology [Oral Oncol] 2017 Sep; Vol. 72, pp. 90-97. Date of Electronic Publication: 2017 Jul 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Radiotherapy, Intensity-Modulated*
Carcinoma, Squamous Cell/*radiotherapy
Carcinoma, Squamous Cell/*surgery
Mouth Neoplasms/*radiotherapy
Mouth Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/pathology ; Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged ; Mouth Neoplasms/pathology ; Postoperative Care ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow.
Autorzy :
Mohamed ASR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt. .
Wong AJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Fuller CD; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Kamal M; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Ain-Shams, Cairo, Egypt.
Gunn GB; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Phan J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Morrison WH; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Beadle BM; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Skinner H; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Quinlan-Davidson SR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Radiation Oncology, Allentown Radiation Oncology Associates, Allentown, PA, USA.
Belal AM; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
El-Gowily AG; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Frank SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Rosenthal DI; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Garden AS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2017 Aug 15; Vol. 12 (1), pp. 129. Date of Electronic Publication: 2017 Aug 15.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Mouth Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Radiometry ; Radiotherapy, Adjuvant/methods ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck ; Young Adult
Czasopismo naukowe
Tytuł :
Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.
Autorzy :
Shiao JC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Messer JA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas Medical Branch, Galveston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson JM; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Enderling H; Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Ain Shams, Cairo, Egypt.
Warren BW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pham B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kies MS; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Schomer DF; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2017 Aug; Vol. 39 (8), pp. 1609-1620. Date of Electronic Publication: 2017 May 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Tumor Burden*
Carcinoma, Squamous Cell/*pathology
Laryngeal Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/diagnostic imaging ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/therapy ; Combined Modality Therapy ; Cone-Beam Computed Tomography ; Female ; Humans ; Laryngeal Neoplasms/diagnostic imaging ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/therapy ; Laryngectomy ; Larynx/diagnostic imaging ; Larynx/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Radiotherapy ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Autorzy :
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Ain Shams University, Cairo, Egypt.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Peters LJ; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Aug 01; Vol. 98 (5), pp. 1002-1011. Date of Electronic Publication: 2017 Jul 10.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Dose-Response Relationship, Radiation ; Female ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/surgery ; Humans ; Hypopharyngeal Neoplasms/mortality ; Hypopharyngeal Neoplasms/pathology ; Hypopharyngeal Neoplasms/radiotherapy ; Hypopharyngeal Neoplasms/surgery ; Kaplan-Meier Estimate ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/pathology ; Laryngeal Neoplasms/radiotherapy ; Laryngeal Neoplasms/surgery ; Male ; Margins of Excision ; Middle Aged ; Mouth Neoplasms/mortality ; Mouth Neoplasms/pathology ; Mouth Neoplasms/radiotherapy ; Mouth Neoplasms/surgery ; Oropharyngeal Neoplasms/mortality ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/radiotherapy ; Oropharyngeal Neoplasms/surgery ; Postoperative Care ; Prospective Studies ; Radiotherapy/adverse effects ; Radiotherapy Dosage ; Survival Rate ; Time Factors
Czasopismo naukowe
Tytuł :
ECOG-ACRIN 1308: Commentary on a Negative Phase II Trial.
Autorzy :
Garden AS; Adam S. Garden and Pierre Blanchard, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blanchard P; Adam S. Garden and Pierre Blanchard, The University of Texas MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jun 10; Vol. 35 (17), pp. 1969-1970. Date of Electronic Publication: 2017 Apr 21.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Squamous Cell*
Papillomavirus Infections*
Cetuximab ; Humans ; Induction Chemotherapy ; Oropharynx
Opinia redakcyjna
Tytuł :
Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.
Autorzy :
Quinlan-Davidson SR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Myers JN; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
William WN Jr; Department of Thoracic/Head and Neck Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle BM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gillenwater AM; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo ME; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2017 Apr; Vol. 39 (4), pp. 633-638. Date of Electronic Publication: 2016 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Salvage Therapy*
Carcinoma, Squamous Cell/*therapy
Mouth Neoplasms/*therapy
Neoplasm Recurrence, Local/*therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Cohort Studies ; Combined Modality Therapy ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Mouth Neoplasms/mortality ; Mouth Neoplasms/pathology ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Risk Assessment ; Survival Analysis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Autorzy :
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mohamed AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mulcahy CF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lewin JS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle BM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kocak-Uzel E; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Sisli Etfal Teaching and Research Hospital, Istanbul, Turkey.
Ginsberg LE; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kies MS; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2016 Dec; Vol. 38 (12), pp. 1739-1751. Date of Electronic Publication: 2016 Jul 28.
Typ publikacji :
Journal Article
MeSH Terms :
Neoadjuvant Therapy*
Carcinoma, Squamous Cell/*pathology
Carcinoma, Squamous Cell/*therapy
Head and Neck Neoplasms/*pathology
Head and Neck Neoplasms/*therapy
Laryngeal Neoplasms/*pathology
Laryngeal Neoplasms/*therapy
Adult ; Aged ; Analysis of Variance ; Cancer Care Facilities ; Carcinoma, Squamous Cell/mortality ; Chemotherapy, Adjuvant ; Cohort Studies ; Disease-Free Survival ; Female ; Follow-Up Studies ; Head and Neck Neoplasms/mortality ; Humans ; Kaplan-Meier Estimate ; Laryngeal Neoplasms/mortality ; Laryngectomy/methods ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Proportional Hazards Models ; Radiotherapy, Adjuvant ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck ; Survival Analysis ; Texas ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.
Autorzy :
Bar-Ad V; Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: .
Zhang QE; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
Harari PM; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Axelrod R; Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
Rosenthal DI; University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Trotti A; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Jones CU; Radiological Associates of Sacramento, Sacramento, California.
Garden AS; University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Song G; Virginia Mason Medical Center, Seattle, Washington.
Foote RL; Mayo Clinic, Rochester, Minnesota.
Raben D; University of Colorado Comprehensive Cancer Center, Denver, Colorado.
Shenouda G; McGill University, Montreal, Quebec, Canada.
Spencer SA; University of Alabama at Birmingham, Birmingham, Alabama.
Harris J; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
Le QT; Stanford University Medical Center, Stanford, California.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2016 Aug 01; Vol. 95 (5), pp. 1346-1354. Date of Electronic Publication: 2016 Mar 26.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Carcinoma, Squamous Cell/*mortality
Carcinoma, Squamous Cell/*therapy
Cetuximab/*therapeutic use
Drug Eruptions/*mortality
Head and Neck Neoplasms/*drug therapy
Radiodermatitis/*mortality
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Carcinoma, Squamous Cell/pathology ; Causality ; Chemoradiotherapy ; Comorbidity ; Disease-Free Survival ; Female ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/therapy ; Humans ; Incidence ; Male ; Middle Aged ; Prognosis ; Radiodermatitis/pathology ; Radiotherapy Dosage ; Reproducibility of Results ; Risk Factors ; Sensitivity and Specificity ; Severity of Illness Index ; Squamous Cell Carcinoma of Head and Neck ; Statistics as Topic ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications.
Autorzy :
Mohamed AS; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA. .; Department of Clinical Oncology and nuclear medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt. .
Rosenthal DI; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Awan MJ; Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH, USA.
Garden AS; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Kocak-Uzel E; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA.; Department of Radiation Oncology, Beykent University, Istanbul, Turkey.
Belal AM; Department of Clinical Oncology and nuclear medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
El-Gowily AG; Department of Clinical Oncology and nuclear medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Phan J; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Beadle BM; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Gunn GB; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Fuller CD; Head and Neck Section, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Box 0097, 1515 Holcombe Blvd, Houston, TX, 77030, USA. .; Graduate School of Biomedical Science, University of Texas Health Science Center, Houston, TX, USA. .
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2016 Jul 26; Vol. 11 (1), pp. 95. Date of Electronic Publication: 2016 Jul 26.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Image Interpretation, Computer-Assisted/*methods
Image Interpretation, Computer-Assisted/*standards
Neoplasm Recurrence, Local/*pathology
Radiation Oncology/*methods
Radiation Oncology/*standards
Adult ; Aged ; Carcinoma, Squamous Cell/pathology ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Intensity-Modulated ; Research Design/standards ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck ; Treatment Failure
Czasopismo naukowe
Tytuł :
Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
Autorzy :
Takiar V; Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ma D; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Edson M; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Zafereo ME; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Beadle B; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
William WN Jr; Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kies M; Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
El-Naggar AK; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Weber R; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2016 Jul 15; Vol. 95 (4), pp. 1117-31. Date of Electronic Publication: 2016 Mar 19.
Typ publikacji :
Journal Article
MeSH Terms :
Re-Irradiation*
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/mortality ; Disease-Free Survival ; Female ; Head and Neck Neoplasms/mortality ; Humans ; Male ; Middle Aged ; Radiotherapy, Intensity-Modulated/adverse effects ; Retrospective Studies ; Salvage Therapy ; Squamous Cell Carcinoma of Head and Neck
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies